Present cohort n = 178 | |
---|---|
Age, years, mean (range) | 69 (42-91) |
Female gender, n (%) | 62 (35) |
Oxygen saturation in %, mean (SD) | 88 (7) |
Systolic blood pressure in mmHg, mean (SD) | 142 (26) |
Heart rate, per minute, mean (SD) | 93 (19) |
Temperature (°C), mean (SD) | 37.5 (84) |
14 days glucocorticoid treatment n (%) | 96 (54) |
5 days glucocorticoid treatment n (%) | 82 (46) |
COPD GOLD grade, n (%) | |
I | 24 (13) |
II | 60 (34) |
III | 94 (53) |
IV | 0 |
Dyspnea Score (Scale 1-5), n (%) | |
1 | 5 (3) |
2 | 17 (10) |
3 | 22 (12) |
4 | 50 (28) |
5 | 76 (43) |
NA | 8 (4) |
Home oxygen requirement, n (%) | |
Yes | 21 (12) |
No | 156 (87) |
NA | 1 (1) |
Smoking status, n (%) | |
Active | 80 (45) |
Stopped | 98 (55) |
NA | 0 (0) |
Glucocorticoid treatment before admission (iv + oral), n (%) | |
Yes | 34 (19) |
No | 144 (81) |
NA | 0 (0) |
Antibiotic treatment before admission, n (%) | |
Yes | 33 (19) |
No | 144 (80) |
NA | 1 (1) |
Outcome | |
Re-exacerbation within 180 days, n (%) | |
Overall | 65 (36) |
5 days glucocorticoid group | 24 (29), n=82 |
14 days glucocorticoid group | 41 (43), n=96 |
Death within 180 days, n (%) | |
Overall | 7 (4) |
5 days glucocorticoid group | 3 (4), n=82 |
14 days glucocorticoid group | 4 (4), n=96 |
Death or exacerbation within 180 days, n (%) | |
Overall | 67 (38) |
5 days glucocorticoid group | 24 (29), n=82 |
14 days glucocorticoid group | 43 (45), n=96 |